| β-PEA | β-phenylethylamine |
| T1AM | 3-iodothyronamine |
| TMA | trimethylamine |
| CHA | cyclohexylammonium ion |
| METH | methamphetamine |
| AMPH | amphetamine |
| (Q)SAR | (quantitative) structure-activity relationship |
| HM | homology model |
| VS | virtual screening |
| HTS | high throughput screening |
| ROC-AUC | (receiver operating characteristic-area under the curve) |
| RMSD | root mean square deviation |
| AF | AlphaFold |
| β2-ADR | β2-adrenoreceptor |
| 5-HT6R | 5-hydroxytryptamine receptor 6 |
| 5-HT2AR | 5-hydroxytryptamine receptor 2A |
| 5-HT2BR | 5-hydroxytryptamine receptor 2B |
| M3R | muscarinic acetylcholine receptor |
| D1R | dopamine D1 receptor |
| α1A-ADR | α1A-adrenergic receptor |
| α1B-ADR | α 1B-adrenergic receptor |
| α2A-ADR | α2A-adrenergic receptor |
| H2R | hystidine receptor type 2 |
| SEP-363856 | ulotaront |
| RO-6889450 | ralmitaront |